Different Dopaminergic abnormalities underlie cannabis dependence and cannabis-induced psychosis

Biological Psychiatry

Volumn 75, Issue 6, 2014, Pages 430-431

  Murray, Robin M ^a   Mehta, Mitul ^a   Di Forti, Marta ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CANNABIS ADDICTION; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOSIS;

ANIMALS; DOPAMINERGIC NEURONS; HUMANS; MARIJUANA ABUSE; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 84894468955     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.01.011     Document Type: Note

References (12)

1. P. Casadio, K. Fernandes, R.M. Murray, and M. Di Forti Cannabis use in young people: The risk for schizophrenia Neurosci Biobehav Rev 35 2011 1779 1781
2. M. Di Forti, H. Sallis, F. Allegri, A. Trotta, L. Ferraro, and S.A. Stilo et al. Daily use, especially of high potency cannabis, drives the earlier onset of psychosis in cannabis users [published online ahead of print Dec 17] Schizophr Bull 2013
3. R.M. Murray, P.D. Morrison, C. Henquet, and M. Di Forti Cannabis, the mind and society: The hash realities Nat Rev Neurosci 8 2007 885 895
4. O.D. Howes, and R.M. Murray Schizophrenia: An integrated sociodevelopmental-cognitive model [published online ahead of print Dec 5] Lancet 2013
5. M.G. Bossong, B.N. van Berckel, R. Boellaard, L. Zuurman, R.C. Schuit, and A.D. Windhorst et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum Neuropsychopharmacology 34 2009 759 766
6. R. Kuepper, J. Ceccarini, J. Lataster, J. van Os, M. van Kroonenburgh, and J.M. van Gerven et al. Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: (18)F-Fallypride positron emission tomography study PLoS One 8 2013 e70378
7. M.A.P. Bloomfield, C.J.A. Morgan, A. Egerton, S. Kapur, H.V. Curran, and O.D. Howes Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms Biol Psychiatry 75 2014 470 478
8. J.L. Thompson, N. Urban, M. Slifstein, X. Xu, L.S. Kegeles, and R.R. Girgis et al. Striatal dopamine release in schizophrenia comorbid with substance dependence Mol Psychiatry 18 2013 909 915
9. 9-tetrahydrocannabinol exposure induces a sensitization of dopamine D2/3 receptors in the mesoaccumbens and nigrostriatal systems Neuropsychopharmacology 37 2012 2355 2367
10. M.V. Seeman, and P. Seeman Is schizophrenia a dopamine supersensitivity psychotic reaction Prog Neuropsychopharmacol Biol Psychiatry 48 2014 155 160
11. A. Demjaha, A. Egerton, R.M. Murray, S. Kapur, O.D. Howes, J.M. Stone, and P.K. McGuire Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function [published online ahead of print Jul 29] Biol Psychiatry 2013
12. M. Di Forti, C. Iyegbe, H. Sallis, A. Kolliakou, M.A. Falcone, and A. Paparelli et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users Biol Psychiatry 72 2012 811 816